Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 464

1.

Ferritin levels, inflammatory biomarkers, and mortality in peripheral arterial disease: a substudy of the Iron (Fe) and Atherosclerosis Study (FeAST) Trial.

Depalma RG, Hayes VW, Chow BK, Shamayeva G, May PE, Zacharski LR.

J Vasc Surg. 2010 Jun;51(6):1498-503. doi: 10.1016/j.jvs.2009.12.068. Epub 2010 Mar 20.

PMID:
20304584
[PubMed - indexed for MEDLINE]
Free Article
2.

Cytokine signatures in atherosclerotic claudicants.

DePalma RG, Hayes VW, Cafferata HT, Mohammadpour HA, Chow BK, Zacharski LR, Hall MR.

J Surg Res. 2003 May 15;111(2):215-21.

PMID:
12850465
[PubMed - indexed for MEDLINE]
3.

Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial.

Zacharski LR, Chow BK, Howes PS, Shamayeva G, Baron JA, Dalman RL, Malenka DJ, Ozaki CK, Lavori PW.

J Natl Cancer Inst. 2008 Jul 16;100(14):996-1002. doi: 10.1093/jnci/djn209. Epub 2008 Jul 8.

PMID:
18612130
[PubMed - indexed for MEDLINE]
Free Article
4.

Reduction of iron stores and cardiovascular outcomes in patients with peripheral arterial disease: a randomized controlled trial.

Zacharski LR, Chow BK, Howes PS, Shamayeva G, Baron JA, Dalman RL, Malenka DJ, Ozaki CK, Lavori PW.

JAMA. 2007 Feb 14;297(6):603-10.

PMID:
17299195
[PubMed - indexed for MEDLINE]
5.

Statins and biomarkers in claudicants with peripheral arterial disease: cross-sectional study.

DePalma RG, Hayes VW, May PE, Cafferata HT, Mohammadpour HA, Brigg LA, Chow BK, Shamayeva G, Zacharski LR.

Vascular. 2006 Jul-Aug;14(4):193-200.

PMID:
17026909
[PubMed - indexed for MEDLINE]
6.

Implementation of an iron reduction protocol in patients with peripheral vascular disease: VA cooperative study no. 410: the Iron (Fe) and Atherosclerosis Study (FeAST).

Zacharski LR, Chow BK, Howes PS, Lavori PW, Shamayeva G.

Am Heart J. 2004 Sep;148(3):386-92.

PMID:
15389223
[PubMed - indexed for MEDLINE]
7.

Effect of controlled reduction of body iron stores on clinical outcomes in peripheral arterial disease.

Zacharski LR, Shamayeva G, Chow BK.

Am Heart J. 2011 Nov;162(5):949-957.e1. doi: 10.1016/j.ahj.2011.08.013.

PMID:
22093213
[PubMed - indexed for MEDLINE]
8.

Prospective evaluation of the relationship between C-reactive protein, D-dimer and progression of peripheral arterial disease.

Musicant SE, Taylor LM Jr, Peters D, Schuff RA, Urankar R, Landry GJ, Moneta GL.

J Vasc Surg. 2006 Apr;43(4):772-80; discussion 780.

PMID:
16616235
[PubMed - indexed for MEDLINE]
Free Article
9.

Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: a cohort study.

Vidula H, Tian L, Liu K, Criqui MH, Ferrucci L, Pearce WH, Greenland P, Green D, Tan J, Garside DB, Guralnik J, Ridker PM, Rifai N, McDermott MM.

Ann Intern Med. 2008 Jan 15;148(2):85-93.

PMID:
18195333
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers.

Seddon JM, George S, Rosner B, Rifai N.

Arch Ophthalmol. 2005 Jun;123(6):774-82.

PMID:
15955978
[PubMed - indexed for MEDLINE]
11.

Comparison of effects of statin use on mortality in patients with peripheral arterial disease with versus without elevated C-reactive protein and d-dimer levels.

Vidula H, Tian L, Liu K, Criqui MH, Ferrucci L, Guralnik JM, Green D, Ridker P, McDermott MM.

Am J Cardiol. 2010 May 1;105(9):1348-52. doi: 10.1016/j.amjcard.2009.12.054. Epub 2010 Mar 19.

PMID:
20403491
[PubMed - indexed for MEDLINE]
12.

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.

Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, Macfadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Trial Study Group.

Lancet. 2009 Apr 4;373(9670):1175-82. doi: 10.1016/S0140-6736(09)60447-5. Epub 2009 Mar 28.

PMID:
19329177
[PubMed - indexed for MEDLINE]
13.

Statin therapy is associated with improved cardiovascular outcomes and levels of inflammatory markers in patients with heart failure.

Sola S, Mir MQ, Rajagopalan S, Helmy T, Tandon N, Khan BV.

J Card Fail. 2005 Oct;11(8):607-12.

PMID:
16230264
[PubMed - indexed for MEDLINE]
14.

Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease.

Fiotti N, Giansante C, Ponte E, Delbello C, Calabrese S, Zacchi T, Dobrina A, Guarnieri G.

Atherosclerosis. 1999 Jul;145(1):51-60.

PMID:
10428295
[PubMed - indexed for MEDLINE]
15.

Comparison of usefulness of inflammatory markers in patients with versus without peripheral arterial disease in predicting adverse cardiovascular outcomes (myocardial infarction, stroke, and death).

Beckman JA, Preis O, Ridker PM, Gerhard-Herman M.

Am J Cardiol. 2005 Nov 15;96(10):1374-8. Epub 2005 Sep 27.

PMID:
16275181
[PubMed - indexed for MEDLINE]
16.

Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study).

Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K, Tracy RP, Rubin SM, Harris TB, Pahor M.

Am J Cardiol. 2003 Sep 1;92(5):522-8.

PMID:
12943870
[PubMed - indexed for MEDLINE]
17.

Serum ferritin is a marker of morbidity and mortality in hemodialysis patients.

Kalantar-Zadeh K, Don BR, Rodriguez RA, Humphreys MH.

Am J Kidney Dis. 2001 Mar;37(3):564-72.

PMID:
11228181
[PubMed - indexed for MEDLINE]
18.

Atherosclerosis in hemodialysis patients--the role of microinflammation.

Bevc S, Sabic S, Hojs R.

Ren Fail. 2008;30(10):1012-6. doi: 10.1080/08860220802406385.

PMID:
19016154
[PubMed - indexed for MEDLINE]
19.

Combined high serum ferritin and low iron saturation in hemodialysis patients: the role of inflammation.

Rambod M, Kovesdy CP, Kalantar-Zadeh K.

Clin J Am Soc Nephrol. 2008 Nov;3(6):1691-701. doi: 10.2215/CJN.01070308. Epub 2008 Oct 15.

PMID:
18922994
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

The association of biomarkers of iron status with peripheral arterial disease in US adults.

Menke A, Fernández-Real JM, Muntner P, Guallar E.

BMC Cardiovasc Disord. 2009 Aug 3;9:34. doi: 10.1186/1471-2261-9-34.

PMID:
19650928
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk